| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |